CLS looks forward to further expansion
Medtech company Clinical Laserthermia Systems has now joined the group of reporting companies. CEO Dan Mogren visited BioStock’s studio to summarise the most important events during Q3, with a particular focus on the urology and neurology segment. We also talked about the company’s finances and upcoming milestones.
See the interview with CLS‘ CEO Dan Mogren below.
